Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach

Description

This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.

Conditions

Cancer, Tobacco Dependence, Tobacco Use Cessation

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.

Connect Cancer Patients to Tobacco Cessation Care by Automated Interactive Outreach

Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

San Francisco

University of California, San Francisco, San Francisco, California, United States, 94143

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age 18 years and older.
  • 2. Able to understand study procedures and to comply with them for the entire length of the study.
  • 3. Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
  • 4. English, Spanish, Cantonese, or Mandarin speaking.
  • 5. Self-reported current use of tobacco, including e-cigarette on EHR.
  • 6. Has a diagnosis of cancer.
  • 7. Has been seen by a prescribing provider within a UCSF Cancer Center-affiliated clinical department within the past 3 months.
  • 1. Contraindication to any study-related procedure or assessment.
  • 2. No valid contact telephone number.
  • 3. Currently hospitalized or having been discharged from inpatient setting within the past month (according to EHR).

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Janice Tsoh, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2025-01-30